March 7 (Reuters) - U.S. medical devices maker Biomet Inc filed with U.S. regulators on Friday to raise up to $100 million in an initial public offering of its common shares.
The company, which was taken private for $11.4 billion in 2007 by a private equity consortium, said BofA Merrill Lynch, Goldman Sachs and J.P. Morgan were the lead underwriters to the offering. ()
The amount of money a company says it plans to raise in its first IPO filing is used to calculate registration fees. The final size of the IPO could be different.